Liposomal chemotherapy CPX-351: safety profile

CPX-351, a combination of cytarabine (ara-C) and daunorubicin within a liposomal delivery system, was approved in August 2017 for two types of secondary acute myeloid leukemia (AML). Speaking from the... Author: VJHemOnc Added: 03/08/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts